By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BrainStorm Cell Therapeutics Inc. 

Tel Aviv      Israel
Phone: n/a Fax:



Company News
BrainStorm Cell Awarded $2.1 Million Non-Dilutive Grant For 2017 By The Israel Innovation Authority 6/13/2017 7:24:31 AM
BrainStorm Cell Initiated Technology Transfer To City Of Hope For U.S. Production Of NurOwn For Phase lll ALS Study 5/16/2017 11:01:32 AM
BrainStorm Cell Announces First Quarter 2017 Financial Results And Provides Corporate Update 5/15/2017 10:14:09 AM
BrainStorm Cell Announces Publication of NurOwn Autism Research Study 4/19/2017 7:27:44 AM
BrainStorm Cell Announces Financial Results For 2016 And Provides Business Update 3/30/2017 8:52:01 AM
BrainStorm Cell Strengthens Management Team With Appointment Of Ralph Z. Kern, MD, MHSc As Chief Operating Officer And Chief Medical Officer 3/6/2017 8:07:57 AM
BrainStorm Cell Announces MOU With Tel Aviv Sourasky Medical Center To Make NurOwn Available To Patients As A Hospital Exemption Product 3/1/2017 10:03:47 AM
BrainStorm Cell Names Dr. June S. Almenoff And Arturo O. Araya To Its Board Of Directors As Company Prepares For Clinical And Commercial Success 2/27/2017 8:16:06 AM
BrainStorm Cell Seeking Approval To Distribute NurOwn In Canada 2/21/2017 7:25:43 AM
City of Hope To Manufacture NurOwn For BrainStorm Cell's Phase III ALS Clinical Trial 2/16/2017 7:24:32 AM